These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17499871)

  • 21. The value of nonuniform margins for six-field conformal irradiation of localized prostate cancer.
    Pickett B; Roach M; Verhey L; Horine P; Malfatti C; Akazawa C; Dea D; Varad B; Rathbun C; Phillips TL
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):211-8. PubMed ID: 7721618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton therapy coverage for prostate cancer treatment.
    Vargas C; Wagner M; Mahajan C; Indelicato D; Fryer A; Falchook A; Horne D; Chellini A; McKenzie C; Lawlor P; Li Z; Lin L; Keole S
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1492-501. PubMed ID: 18374228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rectal and bladder motion during conformal radiotherapy after radical prostatectomy.
    Fiorino C; Foppiano F; Franzone P; Broggi S; Castellone P; Marcenaro M; Calandrino R; Sanguineti G
    Radiother Oncol; 2005 Feb; 74(2):187-95. PubMed ID: 15734207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study.
    Harsolia A; Vargas C; Yan D; Brabbins D; Lockman D; Liang J; Gustafson G; Vicini F; Martinez A; Kestin LL
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1100-9. PubMed ID: 17967304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance assessment of prostate localization variability in intensity-modulated radiotherapy for prostate cancer.
    Villeirs GM; De Meerleer GO; Verstraete KL; De Neve WJ
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1611-21. PubMed ID: 15590193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer.
    Kupelian PA; Langen KM; Zeidan OA; Meeks SL; Willoughby TR; Wagner TH; Jeswani S; Ruchala KJ; Haimerl J; Olivera GH
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):876-82. PubMed ID: 17011460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study to assess the bladder distension effects on dosimetry in intracavitary brachytherapy of cervical cancer via computed tomography-assisted techniques.
    Sun LM; Huang HY; Huang EY; Wang CJ; Ko SF; Lin H; Song JC
    Radiother Oncol; 2005 Oct; 77(1):77-82. PubMed ID: 15885826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. External beam radiotherapy of bladder carcinoma: considerations in determining the irradiation field margins.
    Bozios G; Capizzello A; Tsekeris P
    J BUON; 2010; 15(3):489-95. PubMed ID: 20941815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiotherapy of bladder cancer: relevance of bladder volume changes in planning boost treatment.
    Miralbell R; Nouet P; Rouzaud M; Bardina A; Hejira N; Schneider D
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):741-6. PubMed ID: 9652833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer.
    Fokdal L; Honoré H; Høyer M; Meldgaard P; Fode K; von der Maase H
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):436-44. PubMed ID: 15145160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy.
    O'Daniel JC; Dong L; Zhang L; de Crevoisier R; Wang H; Lee AK; Cheung R; Tucker SL; Kudchadker RJ; Bonnen MD; Cox JD; Mohan R; Kuban DA
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):883-91. PubMed ID: 17011461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer.
    Hoogeman MS; van Herk M; de Bois J; Lebesque JV
    Radiother Oncol; 2005 Feb; 74(2):177-85. PubMed ID: 15734206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer.
    Bayley AJ; Catton CN; Haycocks T; Kelly V; Alasti H; Bristow R; Catton P; Crook J; Gospodarowicz MK; McLean M; Milosevic M; Warde P
    Radiother Oncol; 2004 Jan; 70(1):37-44. PubMed ID: 15036850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spacer stability and prostate position variability during radiotherapy for prostate cancer applying a hydrogel to protect the rectal wall.
    Pinkawa M; Piroth MD; Holy R; Escobar-Corral N; Caffaro M; Djukic V; Klotz J; Eble MJ
    Radiother Oncol; 2013 Feb; 106(2):220-4. PubMed ID: 23333015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analyses of the dynamic properties of the bladder wall studied by repetitive pelvic CT scans of patients and cryo-sections of cadavers.
    Dale E; Hellebust TP; Bruland ØS; Olsen DR
    Br J Radiol; 2005 Jun; 78(930):528-32. PubMed ID: 15900058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
    Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The comparison of radiotherapy techniques for treatment of the prostate cancer: the three-field vs. the four-field.
    Milecki P; Piotrowski T; Dymnicka M
    Neoplasma; 2004; 51(1):64-9. PubMed ID: 15004663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Online adaptive radiotherapy of the bladder: small bowel irradiated-volume reduction.
    Burridge N; Amer A; Marchant T; Sykes J; Stratford J; Henry A; McBain C; Price P; Moore C
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):892-7. PubMed ID: 17011462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparison.
    Pinkawa M; Piroth MD; Holy R; Fischedick K; Klotz J; Székely-Orbán D; Eble MJ
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):23-8. PubMed ID: 20832182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.